IGS GeboJagema is the leading independent healthcare manufacturer in the tooling market for medical devices — and one of BC Partners’ most recent partnerships.
Our investment builds on our deep expertise backing resilient, high-growth businesses across pharma and specialised manufacturing, with companies including IMA, Synthon, and Pharmathen. From this experience — we bring a repeatable playbook to drive innovation, internationalisation, and operational scale.
With IGS, we’ve hit the ground running. We’ve already signed two strategic acquisitions to expand the business’s capabilities, and invested in systems and CapEx to fuel the next phase of growth.
Hear more about our partnership with IGS from BC Partners’ Matthew Evans:
